Hosted on MSN1mon
Turning point in drug prices is around the corner, says Cantor Fitzgerald's Louise ChenLouise Chen, Cantor Fitzgerald senior analyst, joins ‘Squawk Box’ to discuss Novo Nordisk's CEO on Capitol Hill, when drug prices could start to come down, and more. Supreme Court Hands ...
In a report released yesterday, Louise Chen from Cantor Fitzgerald maintained a Buy rating on AbbVie (ABBV – Research Report), with a ...
A day after Novo Nordisk (NVO) CEO Lars Fruergaard Jørgensen was grilled by a U.S. Senate committee, Cantor Fitzgerald ...
In a report released on September 28, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), with a price target of $215.00. The company’s ...
Louise Chen is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future ...
Pfizer Inc Louise Chen; Analyst; Cantor Fitzgerald & Co. Inc. Geoff Meacham; Analyst; Citigroup Inc. (Operator Instructions) Good day, everyone, and welcome to Pfizer's third-quarter 2024 earnings ...
Thank you for standing by. Welcome to the Merck & Co. Q3 sales and earnings conference call. (Operator Instructions) This call is being recorded. If you have any objections, you may disconnect at this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback